Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

Cardiovascular risk factor Chronic fatigue syndrome Immune score Peripheral endothelial dysfunction Reactive hyperaemia index

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2020
Historique:
received: 01 10 2019
revised: 23 10 2019
accepted: 14 01 2020
pubmed: 11 3 2020
medline: 22 6 2021
entrez: 11 3 2020
Statut: ppublish

Résumé

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisystem disease. Evidence for disturbed vascular regulation comes from various studies showing cerebral hypoperfusion and orthostatic intolerance. The peripheral endothelial dysfunction (ED) has not been sufficiently investigated in patients with ME/CFS. The aim of the present study was to examine peripheral endothelial function in patients with ME/CFS. Thirty-five patients [median age 40 (range 18-70) years, mean body mass index 23.8 ± 4.2 kg/m Peripheral ED is frequent in patients with ME/CFS and associated with disease severity and severity of immune symptoms. As ED is a risk factor for cardiovascular disease, it is important to elucidate if peripheral ED is associated with increased cardiovascular morbidity and mortality in ME/CFS.

Identifiants

pubmed: 32154656
doi: 10.1002/ehf2.12633
pmc: PMC7261521
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1064-1071

Subventions

Organisme : Weidenhammer-Zöbele Foundation
Pays : International

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

J Intern Med. 2012 Jan;271(1):64-81
pubmed: 21615807
Circ Res. 2015 Mar 27;116(7):1143-56
pubmed: 25587098
Vasc Health Risk Manag. 2010 Mar 24;6:135-44
pubmed: 20448798
ESC Heart Fail. 2020 Jun;7(3):1064-1071
pubmed: 32154656
Int Immunopharmacol. 2014 Apr;19(2):308-16
pubmed: 24530918
Fatigue. 2016;4(4):195-207
pubmed: 28070451
Arch Immunol Ther Exp (Warsz). 2017 Dec;65(6):463-475
pubmed: 28361180
Vascul Pharmacol. 2018 Jan;100:1-19
pubmed: 28579545
Autoimmun Rev. 2018 Jun;17(6):601-609
pubmed: 29635081
Expert Opin Ther Targets. 2013 May;17(5):485-500
pubmed: 23448263
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
PLoS One. 2018 Mar 15;13(3):e0193672
pubmed: 29543914
Acta Physiol (Oxf). 2017 Jan;219(1):22-96
pubmed: 26706498
Cerebrovasc Dis. 2012;33(1):37-46
pubmed: 22133764
Int J Cardiol. 2012 Feb 9;154(3):335-6
pubmed: 22078396
Fatigue. 2018;6(2):63-79
pubmed: 29707427
Circulation. 1997 Dec 16;96(12):4219-25
pubmed: 9416885
J Transl Med. 2018 Aug 17;16(1):231
pubmed: 30119681
Stroke. 1998 Sep;29(9):1876-81
pubmed: 9731612
Magn Reson Imaging. 2016 May;34(4):603-8
pubmed: 26708036
Brain Imaging Behav. 2019 Jun;13(3):789-797
pubmed: 29855991
Prev Med. 2009 Dec;49(6):468-72
pubmed: 19804795
Open Heart. 2016 Jun 24;3(1):e000381
pubmed: 27403329
Exerc Immunol Rev. 2014;20:94-116
pubmed: 24974723
Neurology (ECronicon). 2016;4(2):41-45
pubmed: 28066845
PLoS One. 2015 Jul 01;10(7):e0129898
pubmed: 26132314
Clin Physiol Funct Imaging. 2003 Sep;23(5):282-5
pubmed: 12950326
Int J Mol Sci. 2014 Jun 25;15(7):11324-49
pubmed: 24968272
J Intern Med. 2011 Oct;270(4):327-38
pubmed: 21777306
Circulation. 2008 May 13;117(19):2467-74
pubmed: 18458169
Am Heart J. 2003 Jul;146(1):168-74
pubmed: 12851627
QJM. 2007 Aug;100(8):519-26
pubmed: 17617647
Mayo Clin Proc. 2012 Dec;87(12):1196-201
pubmed: 23218087
Eur Heart J. 2010 May;31(9):1142-8
pubmed: 20181680
J Am Heart Assoc. 2017 Sep 11;6(9):
pubmed: 28893762
Br J Anaesth. 2004 Jul;93(1):105-13
pubmed: 15121728
Expert Rev Cardiovasc Ther. 2018 Dec;16(12):879-887
pubmed: 30354851
Respir Med. 2008 Dec;102(12):1791-6
pubmed: 18678478
J Am Med Dir Assoc. 2017 Mar 1;18(3):240-245
pubmed: 27816483
J Auton Nerv Syst. 1999 Feb 15;75(2-3):192-201
pubmed: 10189122
Curr Diabetes Rev. 2020;16(3):230-237
pubmed: 30332971
Sci Rep. 2018 Feb 9;8(1):2779
pubmed: 29426834

Auteurs

Nadja Scherbakov (N)

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.

Marvin Szklarski (M)

Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Jelka Hartwig (J)

Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Franziska Sotzny (F)

Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Sebastian Lorenz (S)

Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Antje Meyer (A)

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353, Berlin, Germany.
Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.

Patricia Grabowski (P)

Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Wolfram Doehner (W)

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.

Carmen Scheibenbogen (C)

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353, Berlin, Germany.
Institute of Medical Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH